Seattle Genetics Announces Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations at the International Conference on Malignant Lymphoma
June 17, 2015 at 09:01 AM EDT
Seattle Genetics, Inc. (NASDAQ: SGEN) today announced several ADCETRIS (brentuximab vedotin) data presentations at the 13th ...